Search Results - A. Yu. Babenko

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia by D. A. Lebedev, A. Yu. Babenko

    Published in Медицинский совет (2018-09-01)
    Get full text
    Article


  2. 2

    Glucagon-like peptide-1 receptor agonists, selection within the class. The rational combination of insulin glargine 100 + lixisenatide by M. V. Martjanova, A. Yu. Babenko

    Published in Медицинский совет (2020-05-01)
    Get full text
    Article


  3. 3

    Fibrosis biomarkers and echocardiographic parameters in patients with type 2 diabetes depending on the degree of albuminuria by D. A. Lebedev, M. Yu. Laevskaya, A. Yu. Babenko

    Get full text
    Article


  4. 4

    GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION by A. Yu. BABENKO, V. A. ZYKOV, E. N. GRINEVA

    Published in Медицинский совет (2016-12-01)
    Get full text
    Article


  5. 5

    Main results of the ADVANCE study: clinical interpretation for endocrinologists by Alsu Gafurovna Zalevskya, A Yu Babenko, A R Volkova

    Published in Сахарный диабет (2009-06-01)
    Get full text
    Article


  6. 6

    Biomarkers associated with atherogenesis: current status and promising areas by M. A. Magruk, A. A. Mosikyan, A. Yu. Babenko

    Get full text
    Article


  7. 7

    Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor by D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko

    Get full text
    Article


  8. 8

    Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis by D. A. Lebedev, E. A. Lyasnikova, E. Yu Vasilyeva, A. Yu Babenko, E. V. Shlyakhto

    Published in Journal of Diabetes Research (2020-01-01)
    Get full text
    Article


  9. 9

    Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels by S. A. Skoryukova, M. V. Kim, A. A. Bystrova, A. Yu. Babenko, E. I. Baranova, S. N. Pchelina

    Get full text
    Article


  10. 10

    Evaluation eff ects of IDPP4 therapy diff erent duration on the functional state of α- and β- cells in patients with type 2 diabetes mellitus by T. P. Tuchina, I. A. Kolchanova, A. R. Meltonyan, L. K. Abramyan, A. Yu. Babenko, M. M. Galagudza

    Get full text
    Article


  11. 11

    Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes by D. A. Lebedev, E. A. Lyasnikova, A. A. Vasilyeva, E. Yu. Vasilyeva, A. Yu. Babenko, E. V. Shlyakhto

    Get full text
    Article


  12. 12

    Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered qu... by E. A. Lyasnikova, A. A. Kuular, A. V. Pavlovskaya, A. N. Vlasenko, A. V. Kozlenok, A. Yu. Babenko, M. Yu. Sitnikova, E. V. Shlyakhto

    Get full text
    Article


  13. 13

    «SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY by S.A. Abzaliyeva, G. A. Junusbekova, I.V. Zhirov, G.K. Zhusupova, K.B. Abzaliyev, M.K. Tundybaeva, R.B. Bazarbekova, A.M. Raisova, A.Yu. Babenko, V.A. Ionin

    Published in Interdisciplinary Approaches to Medicine (2022-12-01)
    Get full text
    Article


  14. 14

    Predictors of carotid artery restenosis after carotid endarterectomy by E. P. Kolesova, E. V. Verkhovskaya, A. G. Vanyurkin, E. K. Zaykova, V. V. Kvan, O. V. Kalinina, M. A. Chernyavsky, A. L. Maslyansky, A. N. Yakovlev, A. Yu. Babenko, A. O. Konradi, E. V. Shlyakhto

    Get full text
    Article


  15. 15

    Features of the atherosclerotic plaque microbiome in patients after carotid endarterectomy by E. P. Kolesova, M. A. Chernyavsky, A. G. Vanyurkin, E. V. Verkhovskaya, E. K. Zaykova, O. V. Kalinina, S. I. Sitkin, A. L. Maslyansky, V. V. Kvan, E. Yu. Vasilyeva, A. N. Yakovlev, A. Yu. Babenko, A. O. Konradi, E. V. Shlyakhto

    Get full text
    Article


  16. 16

    THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES by M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov

    Get full text
    Article


  17. 17

    Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian associa... by I. I. Dedov, N. G. Mokrysheva, M. V. Shestakova, T. V. Nikonova, A. Yu. Mayorov, G. R. Galstyan, M. Sh. Shamhalova, V. O. Barysheva, A. S. Ametov, M. B. Antsiferov, A. Yu. Babenko, T. P. Bardymova, F. V. Valeeva, A. A. Vachugova, E. N. Grineva, T. Yu. Demidova, T. P. Kiseleva, M. A. Kunicyna, T. N. Markova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, V. V. Saluhov, L. A. Suplotova, E. L. Hadarceva, Yu. Sh. Halimov

    Published in Сахарный диабет (2022-03-01)
    Get full text
    Article


Search Tools: